Concert Pharma (CNCE) Announces Results of CTP-656 Phase 1; Demonstrated Superior PK Profile to Kalydeco
Go back to Concert Pharma (CNCE) Announces Results of CTP-656 Phase 1; Demonstrated Superior PK Profile to Kalydeco| CONCERT PHARMACEUT (NASDAQ: CNCE) | Delayed: 8.37 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.37 | 52 Week High | $23.96 | |||
| Open | $8.37 | 52 Week Low | $7.50 | |||
| Day High | $8.37 | P/E | N/A | |||
| Day Low | $8.37 | EPS | $-1.86 | |||
| Volume | 349,046 | |||||
